Mytos
This foundational role within the Business Development team focuses on scaling the company's Proof of Value study framework to bring life-saving regenerative medicines to patients sooner. The position involves driving the full sales funnel, from creative prospecting and pipeline generation to closing complex deals with scientific and economic buyers in the biotech and life sciences sectors. Success in this role requires a hunter mindset, deep scientific fluency, and the ability to sell on value rather than price or features.
Headquarters
London, England, United Kingdom
Company Size
11-50 employees
Founded
2016
Mytos is an automated regenerative medicine CDMO that helps scale cell- and tissue-based therapies. Its proprietary iDEM automation platform standardizes and automates manufacturing to deliver faster, more reproducible, and cost-efficient production at clinical and commercial scale. Mytos partners with biotech developers to manufacture cell therapies across indications (recent deals include programs for bone fractures, deafness, and corneal blindness). Their mission is to enable millions of patients to access regenerative medicine by bringing industrial‑scale automation and GMP manufacturing to complex living therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mytos.